Brief: Bioventus Reports Q4 Adjusted Loss Per Share Of $0.06
March 31 (Reuters) - Bioventus Inc BVS.O :
* BIOVENTUS REPORTS FOURTH QUARTER AND FULL-YEAR 2022
FINANCIAL
RESULTS
* QTRLY NET SALES OF $125.8 MILLION, DOWN 3.5%
* QTRLY LOSS PER SHARE OF CLASS A COMMON STOCK OF $0.52
* QTRLY NON-GAAP LOSS PER SHARE OF $0.06
* Q4 EARNINGS PER SHARE VIEW $0.05 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX881D3p
Further company coverage: BVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioventus
See all newsBioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks
U.S. STOCKS ON THE MOVE-American Eagle Outfitters, gold miners, EPAM
U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus
Bioventus rises after better-than-expected quarterly results